Aescap Venture Management BV

Sector

Biomedical

Status

Deal Promoting Partner

Contact

Patrick Krol
Tel: +31 20 570 29 45
Email: pkrol@aescap.com

Aescap Venture Management BV, is a venture capital firm focusing on the creation and growth of European (bio)medical companies. Through early and active involvement in the companies, Aescap Venture will achieve an accelerated development of its portfolio companies and their products.

In August 2006 Aescap announced that Aescap Venture Fund I had a first close at €59 million. The fund is still open to new investors.

The founders of Aescap are Michiel de Haan, founder and CEO of Atlas Venture until 2000, and Dinko Valerio PhD, founder and former CEO of Crucell, a Euronext / NASDAQ-listed biotechnology company. Additional partners are Patrick Krol MBA, a successful entrepreneur and expert in life sciences marketing and business development, and Kreske Nickelsen MSc/MBA, previous director at 3i, with eight years of experience in life sciences venture capital.

For more information, please visit the Aescap website